Design and Development of a New Glucagon-Like Peptide-1 Receptor Agonist to Obtain High Oral Bioavailability.
Hao ChenYun LuShuai ShiQiang ZhangXiaoli CaoLei SunDong AnXiaojie ZhangXianglin KongJianping LiuPublished in: Pharmaceutical research (2022)
We believe that the design and development of oral SHR-2042 will provide a new way to design more and more GLP-1RAs with high oral bioavailability in the future.
Keyphrases